Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Statistics in Medicine
|
August 18, 2012
Statistical methods for assessing interchangeability of biosimilars
Shein-Chung Chow, Lan-Yan Yang, Aijing Starr, et al.
Plos One
|
January 31, 2008
Multiplex RT-PCR amplification of HIV genes to create a completely autologous DC-based immunotherapy for the treatment of HIV infection
Irina Tcherepanova, Jason Harris, Aijing Starr, et al.
Plos One
|
June 12, 2009
The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90
Irina Tcherepanova, Aijing Starr, Brad Lackford, et al.
The American Journal of Medicine
|
January 28, 2010
Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes
Renato D Lopes, Aijing Starr, Carl F Pieper, et al.
Investigational New Drugs
|
April 9, 2014
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors
Fatima Rangwala, Johanna C Bendell, Mark F Kozloff, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Statistics in Medicine
|
August 18, 2012
Statistical methods for assessing interchangeability of biosimilars
Shein-Chung Chow, Lan-Yan Yang, Aijing Starr, et al.
Plos One
|
January 31, 2008
Multiplex RT-PCR amplification of HIV genes to create a completely autologous DC-based immunotherapy for the treatment of HIV infection
Irina Tcherepanova, Jason Harris, Aijing Starr, et al.
Plos One
|
June 12, 2009
The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90
Irina Tcherepanova, Aijing Starr, Brad Lackford, et al.
The American Journal of Medicine
|
January 28, 2010
Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes
Renato D Lopes, Aijing Starr, Carl F Pieper, et al.
Investigational New Drugs
|
April 9, 2014
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors
Fatima Rangwala, Johanna C Bendell, Mark F Kozloff, et al.
Page
of 1